Elevance Health Inc (ELV) Stock Forecast
US · Healthcare
Current price
$387.32
Market cap
$84.11B
Mean price target
$418.67
Implied upside
8.1%
Key takeaways
- Analysts rate Elevance Health Inc a “Buy”, with a mean price target of $418.67 — about 8.1% upside from the current $387.32, based on 21 analysts.
- ELV is trading in the middle of its 52-week range, at 74% of the $273.71–$426.98 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 21 |
| Mean target | $418.67 |
| High target | $498.00 |
| Low target | $331.00 |
| Rating split (SB / B / H / S / SS) | 3 / 11 / 8 / 0 / 0 |
Price & trading
| Current price | $387.32 |
|---|---|
| Previous close | $384.00 |
| 52-week high | $426.98 |
| 52-week low | $273.71 |
| 50-day average | $379.19 |
| Beta | 0.68 |
See the full ELV breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Elevance Health Inc (ELV) share price?
- Elevance Health Inc last traded at $387.32 with a market capitalisation of about $84.1B.
- What is the analyst price target for ELV?
- The mean analyst price target for Elevance Health Inc is $418.67, roughly 8.1% above the latest price. The current consensus rating is “Buy”.
- Where can I see Elevance Health Inc's full financial metrics?
- Luminoso tracks ELV's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.